+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search in Oncology Drugs returned 5,302 results.

BRAF-Mutant Metastatic Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

BRAF-Mutant Metastatic Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anus Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Anus Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Basal Cell Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Basal Cell Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bile Duct Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Bile Duct Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Biliary Tract Cancer (BTC)- Pipeline Insight, 2025 - Product Thumbnail Image

Biliary Tract Cancer (BTC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Bladder Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Bladder Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
Bone Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Bone Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 550 Pages
  • Global
From
Cutaneous T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Endometrial Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Endometrial Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
HER2-Positive Early Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

HER2-Positive Early Breast Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Indolent Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025 - Product Thumbnail Image

Myelodysplastic Syndrome With Excess Blasts2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Loading Indicator